ARQIT QUANTUM INC (ARQQ)

KYG0567U1013 - Common Stock

30.5  +3.57 (+13.26%)

After market: 30.8 +0.3 (+0.98%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ARQQ. ARQQ was compared to 279 industry peers in the Software industry. While ARQQ seems to be doing ok healthwise, there are quite some concerns on its profitability. ARQQ does not seem to be growing, but still is valued expensively.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

ARQQ had negative earnings in the past year.
In the past 5 years ARQQ reported 4 times negative net income.
In the past 5 years ARQQ always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of ARQQ (-204.28%) is worse than 96.42% of its industry peers.
ARQQ has a worse Return On Equity (-461.85%) than 87.10% of its industry peers.
Industry RankSector Rank
ROA -204.28%
ROE -461.85%
ROIC N/A
ROA(3y)-74.09%
ROA(5y)-45.92%
ROE(3y)-161.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ARQQ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

4

2. Health

2.1 Basic Checks

ARQQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ARQQ has been reduced compared to 1 year ago.
Compared to 1 year ago, ARQQ has an improved debt to assets ratio.

2.2 Solvency

ARQQ has an Altman-Z score of 6.97. This indicates that ARQQ is financially healthy and has little risk of bankruptcy at the moment.
ARQQ's Altman-Z score of 6.97 is fine compared to the rest of the industry. ARQQ outperforms 72.04% of its industry peers.
ARQQ has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.06, ARQQ perfoms like the industry average, outperforming 55.20% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 6.97
ROIC/WACCN/A
WACC8.75%

2.3 Liquidity

ARQQ has a Current Ratio of 1.94. This is a normal value and indicates that ARQQ is financially healthy and should not expect problems in meeting its short term obligations.
ARQQ's Current ratio of 1.94 is in line compared to the rest of the industry. ARQQ outperforms 58.06% of its industry peers.
ARQQ has a Quick Ratio of 1.94. This is a normal value and indicates that ARQQ is financially healthy and should not expect problems in meeting its short term obligations.
ARQQ has a Quick ratio (1.94) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.94

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ARQQ have decreased strongly by -1933.96% in the last year.
ARQQ shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -54.22%.
EPS 1Y (TTM)-1933.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-258.49%
Revenue 1Y (TTM)-54.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-72.81%

3.2 Future

The Earnings Per Share is expected to grow by 28.24% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 783.92% on average over the next years. This is a very strong growth
EPS Next Y66.15%
EPS Next 2Y44.18%
EPS Next 3Y28.24%
EPS Next 5YN/A
Revenue Next Year1144.19%
Revenue Next 2Y2230.09%
Revenue Next 3Y783.92%
Revenue Next 5YN/A

3.3 Evolution

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ARQQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ARQQ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ARQQ's earnings are expected to grow with 28.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.18%
EPS Next 3Y28.24%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ARQQ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARQIT QUANTUM INC

NASDAQ:ARQQ (12/20/2024, 8:00:01 PM)

After market: 30.8 +0.3 (+0.98%)

30.5

+3.57 (+13.26%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-22 2024-11-22/amc
Earnings (Next)N/A N/A
Inst Owners5.88%
Inst Owner Change-98.33%
Ins Owners10.65%
Ins Owner ChangeN/A
Market Cap435.85M
Analysts82.86
Price Target22.44 (-26.43%)
Short Float %7.27%
Short Ratio0.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-56%
PT rev (3m)1000%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)23.5%
EPS NY rev (3m)-1812.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-46.94%
Revenue NY rev (3m)-46.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1487.53
P/FCF N/A
P/OCF N/A
P/B 36.88
P/tB 44.12
EV/EBITDA N/A
EPS(TTM)-10.78
EYN/A
EPS(NY)-1.56
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.02
BVpS0.83
TBVpS0.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -204.28%
ROE -461.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-74.09%
ROA(5y)-45.92%
ROE(3y)-161.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.94
Altman-Z 6.97
F-ScoreN/A
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1933.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-258.49%
EPS Next Y66.15%
EPS Next 2Y44.18%
EPS Next 3Y28.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-54.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-72.81%
Revenue Next Year1144.19%
Revenue Next 2Y2230.09%
Revenue Next 3Y783.92%
Revenue Next 5YN/A
EBIT growth 1Y35.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.41%
EBIT Next 3Y63.99%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A